Congenital tufting enteropathy, also called CTE, is a very rare inherited intestinal disease that usually starts in the first days or weeks of life. The bowel lining is abnormal, so the intestine cannot absorb water, salts, and nutrients well. This causes severe watery diarrhea, dehydration, poor weight gain, and long-term intestinal failure. Many cases are linked to changes in the EPCAM gene, and some syndromic cases are linked to SPINT2. The main treatment is supportive care, especially long-term nutrition and fluid support, because there is no established disease-specific curative medicine for most patients. [1] [2] [3]
Congenital tufting enteropathy is different from common diarrhea because it is not usually caused by infection, bad food, or temporary inflammation. The problem is built into the intestinal lining itself. On biopsy, doctors often see villous injury and the typical “tufts” of surface epithelial cells. Because the intestine keeps losing fluids and nutrients, many children need parenteral nutrition, which means nutrition delivered into a vein. In severe cases, intestinal transplantation can become the only accepted definitive treatment, although it is usually reserved for selected patients because it is a major procedure with major risks. [1] [4] [5]
Congenital tufting enteropathy, often called CTE, is a very rare inherited disease of the intestine. It usually starts in the first days or first weeks of life. A baby with this disease has very severe watery diarrhea that does not stop easily, even when feeding is changed or the bowel is rested. Because of this, the baby loses a lot of water, salts, calories, and nutrients. Over time, this can cause dehydration, poor weight gain, malnutrition, and intestinal failure. Under the microscope, doctors see special changes in the small bowel lining, especially villous atrophy and small crowded groups of surface cells called “tufts.” These findings help doctors make the diagnosis. [GARD]
This disease happens because the bowel lining cells do not stick together and work normally. In many patients, the problem is caused by harmful changes in the EPCAM gene. In a smaller group, especially patients who also have features outside the bowel, the problem can be caused by changes in SPINT2. The disease is usually inherited in an autosomal recessive way, which means a child receives a nonworking copy of the gene from both parents. Some reports show it is more common in families with parental blood relation, also called consanguinity, and in some founder populations. [PMC review]
Another Names
Congenital tufting enteropathy is also called intestinal epithelial dysplasia, IED, congenital diarrhea 5 with tufting enteropathy, non-syndromic congenital tufting enteropathy, and congenital familial intractable diarrhea with epithelial or epithelium abnormalities. Some databases also list names linked to EPCAM secretory diarrhea. [GARD]
Types
Non-syndromic congenital tufting enteropathy means the disease mainly affects the intestine and is most often linked to EPCAM changes. [Diet review; mouse/review background]
Syndromic congenital tufting enteropathy means the child has the bowel disease plus other body findings, such as choanal atresia, eye problems like keratitis, anal anomalies, or other extraintestinal findings. This form is more often linked to SPINT2 changes. [Older Orphanet review; 2023 review]
Severe early neonatal form starts in the first days after birth with heavy diarrhea and fast dehydration. This is the most classic pattern. [Orphanet review]
Milder or later-recognized form can still be congenital but may be diagnosed later because the diarrhea is less dramatic at first or early biopsies do not clearly show the typical tufts. [Review and case literature]
Causes
There are not separate proven direct causes of congenital tufting enteropathy in the medical literature. The main evidence-based direct causes are harmful changes in EPCAM and, in syndromic cases, SPINT2. A few patients with typical disease do not have changes in either gene, so researchers think other genes may exist, but they have not yet been clearly proven for routine clinical use. To stay accurate, the points below explain the known causes and disease mechanisms instead of inventing unsupported causes. [2020 and 2023 reviews]
- Biallelic EPCAM mutation is the best-known direct cause and explains most classic CTE cases. [NCBI/PMC]
- Loss-of-function SPINT2 mutation can cause the syndromic form with bowel and extraintestinal problems. [2023 review]
- Autosomal recessive inheritance causes disease when both gene copies are affected. [Orphanet review]
- Carrier parents can pass one changed copy each to an affected child. [GARD]
- Parental consanguinity raises the chance that both parents carry the same recessive mutation. [Orphanet review]
- Founder mutations in some populations can make the disease more frequent in certain communities. [Review references]
- Abnormal cell adhesion in the intestinal lining is a core mechanism of disease. [Diet review; 2023 review]
- Loss of EpCAM protein function weakens the bowel lining. [2023 review]
- Barrier failure of the intestinal epithelium allows poor control of water and electrolyte movement. [2023 review]
- Disorganization of villi reduces normal absorption. [Diet review]
- Villous atrophy decreases the surface area needed for nutrient and fluid absorption. [NCBI MedGen; Orphanet review]
- Crypt hyperplasia and abnormal regeneration are part of the tissue damage pattern. [Orphanet review]
- Surface epithelial “tufts” show that enterocytes are crowded and abnormal. [Orphanet review; 2020 review]
- Abnormal basement membrane proteins such as laminin and heparan sulfate proteoglycan have been reported. [Orphanet review]
- Abnormal desmosomes and desmoglein expression suggest defective cell-cell attachment. [Orphanet review]
- Abnormal integrin distribution has also been described in affected bowel tissue. [Orphanet review]
- Loss of claudin stabilization is thought to worsen tight-junction problems. [2023 review]
- Nutrient malabsorption develops because the damaged intestine cannot absorb normally. [Diet review]
- Water and electrolyte loss leads to the severe secretory-type diarrhea picture. [Orphanet review; 2023 review]
- Possible other undiscovered genes may explain rare patients without EPCAM or SPINT2 variants, but this is still under research. [2020 review]
Symptoms
- Severe watery diarrhea is the main symptom. It often starts in the first days after birth and continues for a long time. [GARD; Orphanet review]
- Intractable diarrhea means the diarrhea is hard to stop and may continue even with bowel rest. [Orphanet review]
- Dehydration happens because the baby loses a lot of fluid in stool. [2023 review]
- Failure to thrive means poor weight gain and poor growth because the body cannot keep enough calories and nutrients. [NCBI MedGen; diet review]
- Malnutrition may appear when nutrients are not absorbed well enough. [Diet review]
- Electrolyte imbalance can happen when sodium and other body salts are lost in stool. [2023 review; Orphanet review]
- Weight loss or poor body growth is common during infancy. [Review]
- Vomiting can happen in some children together with diarrhea. [Review]
- Abdominal distension means the belly looks swollen or bloated. This has been described in reported cases. [Review]
- Intestinal failure can develop when the bowel cannot support growth without parenteral nutrition. [GARD; review]
- Dependence on parenteral nutrition is common in severe patients because normal feeding alone is not enough. [NCBI MedGen; diet review]
- Eye problems such as punctate keratitis may appear, especially in syndromic or associated forms. [Orphanet review]
- Choanal atresia or other malformations may be present in some children, especially in syndromic forms. [Orphanet review; 2023 review]
- Esophageal atresia, anal anomalies, or dysmorphic features have been reported in some patients. [Orphanet review]
- Repeated hospital illness from dehydration and feeding problems may happen because the disease starts very early and can be severe. [GARD; Orphanet review]
Diagnostic Tests
General dehydration check. Doctors look for dry mouth, weak activity, poor tears, poor urine, and sunken eyes or fontanelle because heavy diarrhea can remove body fluid quickly. This does not prove CTE by itself, but it shows disease severity. [2023 review; Orphanet review]
Growth measurement. Doctors measure weight, length, and head growth because failure to thrive is a common clue in infants with congenital enteropathies. [NCBI MedGen]
Abdominal examination. The doctor checks for bloating or abdominal distension, which may happen along with severe diarrhea. [Review]
Eye examination. Looking for punctate keratitis or other eye surface problems can support the diagnosis, especially in syndromic cases. [Orphanet review]
Detailed feeding and stool history. Doctors ask when diarrhea started, whether it began right after birth, whether it continues during bowel rest, and how much stool comes out each day. Early severe persistent diarrhea is a major clue. [Orphanet review]
Family history review. Doctors ask about affected siblings, infant deaths, and parental consanguinity because this disease is usually recessive. [Orphanet review]
Response-to-feeding review. Clinicians check whether symptoms improve with formula changes. In CTE, standard formula changes often do not fully solve the diarrhea. [Review]
Malformation screening at bedside. Doctors look for choanal atresia, anal anomalies, and other congenital findings that may suggest a syndromic form. [Orphanet review; 2023 review]
Blood electrolytes. Sodium, potassium, chloride, bicarbonate, and acid-base tests help show dehydration and salt loss. They also help separate CTE from other congenital diarrheal diseases. [Orphanet review]
Kidney function tests. Urea and creatinine are checked because dehydration can stress the kidneys. [General disease severity in early diarrhea]
Nutrition blood tests. Albumin, protein, iron studies, vitamins, zinc, selenium, calcium, and vitamin D may be checked because long diarrhea and intestinal failure can cause deficiency. [Diet review]
Stool electrolyte testing. Stool sodium and chloride can help rule out congenital chloride diarrhea and congenital sodium diarrhea, which are important look-alike diseases. [Orphanet review]
Stool volume assessment. Very high stool output in a newborn supports a severe congenital diarrheal disorder. [Orphanet review]
Upper intestinal biopsy. This is one of the most important tests. A biopsy can show villous atrophy and the typical epithelial tufts. [NCBI MedGen; 2020 review]
Repeat biopsy when the first biopsy is unclear. Early biopsies may look nearly normal, so repeated biopsy can be needed later to show the classic changes. [Orphanet review; case report summary]
Histology for crypt changes. Pathologists also look for crypt hyperplasia, branching, and pseudocystic crypt appearance. [Orphanet review]
EpCAM immunohistochemistry. Special staining for EpCAM can help support the diagnosis, especially when routine histology is subtle. [Review reference; late diagnosis report]
Electron microscopy or advanced tissue study. This may show ultrastructural desmosomal abnormalities, although it is not always required in every center. [Orphanet review]
EPCAM sequencing. Genetic testing for EPCAM is a key confirmatory test in classic non-syndromic CTE. [Diet review; 2023 review]
SPINT2 sequencing, and broader congenital diarrhea panels if needed. This is especially useful when the child has extraintestinal features or when EPCAM testing is negative. [2023 review; 2020 review]
Electrodiagnostic note. There is no standard nerve or muscle electrodiagnostic test that directly diagnoses congenital tufting enteropathy. In practice, tests such as ECG/heart monitoring may be used only to watch for dangerous effects of electrolyte imbalance, not to confirm the bowel disease itself. [Disease mechanism and electrolyte loss]
Non-Pharmacological Treatments
1) Long-term parenteral nutrition (PN). This is the most important treatment for many children with CTE. PN gives protein, sugar, fat, vitamins, minerals, and water directly into a vein when the bowel cannot absorb enough. Its purpose is survival, growth, and brain development. Its mechanism is simple: it bypasses the damaged intestine and feeds the body directly. [1] [6]
2) Aggressive fluid replacement. Babies with CTE can lose large amounts of water in stool. Replacing this fluid helps prevent shock, kidney injury, and weakness. The mechanism is restoration of blood volume and tissue perfusion. [1] [4]
3) Electrolyte correction. Sodium, potassium, bicarbonate, magnesium, and other salts can fall during ongoing diarrhea. Replacing them protects the heart, nerves, and muscles and supports normal cell function. [1] [4]
4) Central venous catheter care. Most children on long-term PN need a central line. Strict sterile line care reduces bloodstream infections. The mechanism is prevention of bacteria entering the blood through the catheter. [6]
5) Home parenteral nutrition programs. Once stable, some children can receive PN at home through trained caregivers and specialist teams. This improves quality of life and can reduce long hospital stays. [6]
6) Early referral to an intestinal rehabilitation team. These teams include gastroenterology, surgery, nutrition, pharmacy, and nursing experts. Their purpose is to reduce complications, optimize feeding, and decide when transplant review is needed. [6] [7]
7) Careful enteral feeding trials. Small amounts of gut feeding may be tried if tolerated. The purpose is to stimulate the intestine, support the gut barrier, and keep oral feeding skills active. Response varies widely in CTE. [4] [7]
8) Breast milk or specialized formula selection. Some infants tolerate one feed better than another, even though feeding alone does not cure the disease. The purpose is to find the least irritating and most absorbable nutrition plan. [4] [7]
9) Growth monitoring. Regular checks of weight, length, head growth, and body composition help doctors adjust calories and protein. The mechanism is early detection of underfeeding or overfeeding. [6]
10) Micronutrient monitoring. Children on chronic diarrhea and PN may develop vitamin or trace element problems. Repeated lab checks help prevent anemia, bone disease, immune weakness, and poor healing. [6]
11) Liver surveillance. Long-term PN can damage the liver and bile flow. Monitoring bilirubin, liver enzymes, and ultrasound helps detect PN-associated liver disease early. [6] [8]
12) Infection surveillance. Fever, chills, line redness, and sudden illness can mean catheter sepsis. Early blood cultures and treatment are important because line infections can become life-threatening quickly. [6]
13) Oral rehydration planning. For patients who can take anything by mouth, carefully planned oral fluids may help reduce dehydration episodes. The goal is safer daily hydration, but it does not replace PN in severe disease. [4] [6]
14) Skin and diaper care. Constant watery stool can badly irritate the skin. Barrier creams, frequent changes, and gentle cleaning reduce pain and skin breakdown. [4]
15) Feeding therapy. Children who spend long periods on PN may develop oral aversion. Feeding therapists help maintain sucking, swallowing, chewing, and food acceptance skills. [6]
16) Developmental support. Chronic illness and repeated admissions can affect language, movement, and social development. Early developmental therapy supports better long-term outcomes. [6]
17) Genetic counseling. Because CTE is inherited, families benefit from counseling about recurrence risk, carrier testing, and future pregnancy planning. [1] [3]
18) Biopsy and genetic confirmation. This is not a treatment by itself, but it guides treatment and avoids wrong treatment. Knowing the diagnosis prevents repeated ineffective therapies. [1] [3] [5]
19) Transplant evaluation at the right time. Children with severe intestinal failure, repeated line sepsis, loss of central venous access, or worsening liver disease may need early transplant review. [5] [7]
20) Family training and psychosocial support. Caregivers need training for PN setup, line flushing, infection signs, and emergency action. Strong caregiver education improves safety and can reduce hospital complications. [6]
Drug Treatments
To stay within your word limit, this section lists the most relevant FDA-labeled drugs and PN products used in real care, not 20 disease-specific cures, because CTE has no standard curative drug therapy. [2] [5]
1) Teduglutide (Gattex). Class: GLP-2 analog. FDA use: short bowel syndrome patients who depend on parenteral support. Dose: 0.05 mg/kg once daily subcutaneously. Purpose: reduce PN needs in selected intestinal failure settings. Mechanism: promotes intestinal adaptation and absorptive surface function. Important side effects include abdominal pain, fluid overload, and possible GI complications. It is not approved specifically for CTE, but it may be considered in selected intestinal-failure situations by specialists. [9]
2) Somatropin (Zorbtive). Class: recombinant human growth hormone. FDA use: short bowel syndrome in adults with specialized nutritional support. Purpose: support intestinal adaptation. Mechanism: stimulates growth and may help nutrient absorption in SBS settings. Risks include edema, joint pain, glucose issues, and intracranial hypertension. It is not a standard pediatric CTE treatment, but it is sometimes discussed in intestinal-failure contexts. [10]
3) L-glutamine powder (NutreStore). Class: amino-acid therapy. FDA use: SBS with specialized nutritional support and approved growth hormone. Purpose: support intestinal cell metabolism. Mechanism: glutamine is used by enterocytes and may help gut cell function. Side effects can include edema and abdominal symptoms. This is not proven as standard therapy for CTE, but it appears in intestinal-failure discussion. [11]
4) CLINIMIX. Class: amino acids plus dextrose for intravenous PN. Purpose: calories and protein when oral or enteral feeding is not enough. Mechanism: bypasses the intestine and directly provides protein and energy. Risks include infection, metabolic imbalance, and PN-associated liver disease. [12]
5) KABIVEN. Class: total PN bag with amino acids, dextrose, lipids, and electrolytes. Purpose: complete IV nutrition in selected patients. Mechanism: supplies major macronutrients by vein. Risks include infection, liver complications, and metabolic problems. [13]
6) PERIKABIVEN. Class: PN admixture. Purpose: calories, protein, and essential fatty acids through IV feeding. Mechanism: direct systemic nutrient delivery. Side effects include metabolic derangement and hepatobiliary complications. Pediatric use is limited compared with other products, so specialist use is needed. [14]
7) SMOFlipid. Class: lipid injectable emulsion. Purpose: provide calories and essential fatty acids in PN, including neonates and children. Mechanism: IV lipid energy source. Risks include infection, fat overload, and monitoring needs. [15]
8) Omegaven. Class: fish-oil triglyceride lipid emulsion. FDA use: calories and fatty acids in pediatric patients with PN-associated cholestasis. Purpose: support nutrition when standard PN lipids cause or worsen cholestasis. Mechanism: changes lipid composition and may be gentler on the liver in some children. [16]
9) M.V.I. Pediatric. Class: IV multivitamin. Purpose: prevent vitamin deficiency in children receiving PN. Mechanism: replaces vitamins that are missed when normal gut intake is poor. Side effects can include hypersensitivity and vitamin imbalance if misused. [17]
10) M.V.I. Adult / MVI-12. Class: IV multivitamin for older children or adults on PN. Purpose: maintenance vitamin replacement during PN. Mechanism: direct IV vitamin supply. [18]
11) Tralement. Class: IV trace element combination. Purpose: supply zinc, copper, manganese, and selenium during PN. Mechanism: replaces essential micronutrients that support immunity, growth, antioxidant systems, and enzymes. [19]
12) Ondansetron (Zofran). Class: 5-HT3 antagonist antiemetic. Purpose: control vomiting that may occur during illness or treatment. Mechanism: blocks serotonin-triggered nausea pathways. Side effects include constipation, headache, and QT prolongation. It treats symptoms, not CTE itself. [20]
13) Loperamide (Imodium). Class: antimotility antidiarrheal. Purpose: reduce diarrhea in approved age groups. Mechanism: slows intestinal movement. It must be used very carefully in children and is contraindicated under 2 years because of serious risks. It is not routine first-line therapy in infantile CTE. [21]
14) Pantoprazole IV (Protonix). Class: proton pump inhibitor. Purpose: treat acid-related upper GI disease when needed. Mechanism: lowers stomach acid. It does not treat CTE directly but may be used for associated reflux or ulcer risk. [22]
15) Ursodiol / ursodeoxycholic acid. Class: bile acid. Purpose: sometimes used in cholestatic liver disease by specialists. Mechanism: improves bile flow. Pediatric use is not formally established in the FDA label, so specialist judgment is needed. [23]
16) Dextrose-containing IV solutions. Class: carbohydrate IV support. Purpose: energy and hypoglycemia prevention during acute care. Mechanism: direct glucose delivery to the bloodstream. They are often part of PN or rescue IV therapy. [12] [13]
17) Electrolyte additives for PN. Class: IV electrolyte support. Purpose: replace sodium, potassium, phosphate, and related deficits caused by severe diarrhea and PN needs. Mechanism: restores essential ion balance. These are core supportive therapies in intestinal failure. [12] [13]
18) Individual trace element replacement. Class: mineral supplementation. Purpose: correct low zinc, selenium, copper, or manganese if combination products are not suitable. Mechanism: supports enzyme and immune systems. [19]
19) Individual vitamin replacement. Class: vitamin supplementation. Purpose: correct low vitamins A, D, E, K, C, and B vitamins in PN-dependent patients. Mechanism: prevents deficiency-related bone, blood, skin, and nerve problems. [17] [18]
20) Antibiotics for line sepsis. Class: anti-infectives chosen by culture and hospital protocol. Purpose: treat catheter-related bloodstream infection, a major complication of long-term PN. Mechanism: kill bacteria or fungi. The exact drug depends on cultures, resistance, age, kidney function, and severity. Catheter infection treatment is essential in CTE care. [6]
Dietary Molecular Supplements
These are supportive supplements, not cures. They should only be used if the child’s intestinal team says they are needed. [6] [7]
1) Zinc. Helps immunity, skin healing, and enzyme activity; chronic diarrhea can cause zinc loss.
2) Selenium. Supports antioxidant defense and thyroid-related enzymes.
3) Copper. Helps blood formation and connective tissue function.
4) Iron. Used only when iron deficiency is confirmed, because excess iron can also be harmful.
5) Vitamin D. Supports bones, immunity, and calcium balance. [19] [17]
6) Calcium. Helps bone strength and muscle function.
7) Magnesium. Supports nerves, muscles, and heart rhythm and may be lost with diarrhea.
8) Vitamin K. Important for blood clotting and bone health.
9) Vitamin A. Supports vision, skin, and immune defense.
10) Vitamin B12 and folate. Support blood cells and nerve function, especially in long-term nutritional compromise. [17] [18] [19]
Immunity, Regenerative, or Stem-Cell–Related Options
There are no FDA-approved immune booster, regenerative, or stem-cell drugs specifically for congenital tufting enteropathy. That is the most honest evidence-based answer. Still, these six are the closest relevant categories discussed in intestinal-failure care or research. [2] [5] [24]
1) Teduglutide may support intestinal adaptation in selected intestinal-failure states.
2) Somatropin has an SBS indication in adults and can be discussed only in specialist settings.
3) L-glutamine is an SBS adjunct, not a proven CTE cure.
4) Fish-oil lipid therapy such as Omegaven can support PN-associated cholestasis, which protects long-term nutrition care.
5) Intestinal organoid therapy is experimental research, not approved treatment.
6) Stem-cell-based intestinal regeneration remains experimental and is not standard clinical care for CTE today. [9] [10] [11] [16] [24]
Surgeries or Major Procedures
1) Central venous catheter insertion. This is done to deliver long-term PN safely.
2) Central line replacement or repair. Needed if the line is infected, blocked, damaged, or no longer safe.
3) Intestinal biopsy by endoscopy. Done to confirm the diagnosis by histology.
4) Small bowel transplantation. Considered when intestinal failure is severe or PN complications become dangerous.
5) Multivisceral transplantation. Reserved for very complex cases involving broader abdominal organ failure or anatomy problems. [5] [6] [7]
Prevention Points
CTE itself usually cannot be prevented after conception because it is genetic, but complications can be reduced. Good central-line hygiene, regular liver monitoring, routine blood tests, correct PN mixing, early treatment of fever, careful growth tracking, specialist follow-up, vaccination as advised, avoiding dehydration, and family genetic counseling all help reduce harm. These steps mainly work by preventing infection, malnutrition, liver injury, and late recognition of complications. [6] [7] [1]
When to See Doctors Urgently
See a doctor urgently if there is fever, central-line redness, line leakage, poor feeding, less urine, extreme sleepiness, repeated vomiting, worsening diarrhea, blood in stool, fast breathing, swelling, jaundice, sudden weight loss, or failure to grow. These signs can point to dehydration, sepsis, electrolyte imbalance, liver disease, or nutritional failure. [4] [6] [8]
What to Eat and What to Avoid
Feeding plans must be individualized by the intestinal team. In general, preferred choices may include breast milk if tolerated, specialist formula if prescribed, carefully measured oral or tube feeds, safe clean fluids, and nutrient plans matched to stool losses. Avoid random diet changes, untested herbal products, high-sugar drinks, dehydration, unsafe well water, and stopping PN without medical advice. Also avoid over-the-counter antidiarrheals in infants unless the specialist team clearly instructs it. [6] [7] [21]
FAQs
1) Is CTE contagious? No, it is genetic. [1]
2) Does it start early? Usually yes, often in the newborn period. [1] [4] 3) Is there a cure by medicine? Usually no standard curative drug exists. [2] 4) What is the main treatment? PN and expert intestinal-failure care. [2] [6] 5) Can feeding alone fix it? Usually not in severe disease. [1] [2] 6) Is biopsy important? Yes, it helps confirm the diagnosis. [5] 7) Are genes involved? Yes, often EPCAM and sometimes SPINT2. [3] 8) Can children grow normally? Some can improve with excellent support, but many need long-term intensive care. [6] 9) Is liver disease a risk? Yes, especially with prolonged PN. [8] 10) Are line infections dangerous? Very dangerous, and they need urgent care. [6] 11) Can transplant help? Yes, in selected severe cases. [5] 12) Is teduglutide a cure? No, it may help some intestinal-failure patients but is not a proven CTE cure. [9] 13) Are stem-cell therapies available now? Not as standard approved care. [24] 14) Should families get genetic counseling? Yes. [1] 15) Can care be done at home? Often yes, with trained home PN teams. [6]
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: March 31, 2025.
